B. Dembofsky

发表

Discovery of novel, orally active dual NK1/NK2 antagonists.

W. Rumsey, P. Bernstein, J. Albert, 2001, Bioorganic & medicinal chemistry letters.

Development and SAR of functionally selective allosteric modulators of GABAA receptors.

E. Christian, C. Alhambra, J. Arriza, 2011, Bioorganic & medicinal chemistry.

Design and optimization of cyclized NK1 antagonists with controlled atropisomeric properties

J. Evenden, W. Rumsey, B. Masek, 2004 .

Design, synthesis, and SAR of tachykinin antagonists: modulation of balance in NK(1)/NK(2) receptor antagonist activity.

Daniel C. Hill, W. Rumsey, P. Bernstein, 2002, Journal of medicinal chemistry.

Azepines and piperidines with dual norepinephrine dopamine uptake inhibition and antidepressant activity.

Jian Yu, P. Schroeder, Christopher A. Hurley, 2013, ACS medicinal chemistry letters.

A new lactam protecting group

Michael B. Smith, Y. Son, T. Kwon, 1992 .

Naphtho[2,1-b][1,5] and [1,2-f][1,4]oxazocines as selective NK1 antagonists.

W. Rumsey, B. Masek, P. Bernstein, 2004, Bioorganic & medicinal chemistry.

Bicyclo((aryl)methyl)benzamides as inhibitors of GlyT1.

C. Alhambra, W. Frietze, J. Albert, 2018, Bioorganic & medicinal chemistry letters.

5(R)-Methyl-1-(chloromethyl)-2-pyrrolidinone : a new reagent for the determination of enantiomeric composition of alcohols

Michael B. Smith, Y. Son, B. Dembofsky, 1994 .

Late-occurring and Long-circulating Metabolites of GABAAα2,3 Receptor Modulator AZD7325 Involving Metabolic Cyclization and Aromatization: Relevance to MIST Analysis and Application for Patient Compliance

Mark A. Smith, R. Lewis, J. Hall, 2018, Drug Metabolism and Disposition.